An injectable biomaterial activated by pulses of low-energy blue light has tremendous potential for on-the-spot repair to the domed outer layer of the eye, a team of University of Ottawa researchers and their collaborators have revealed.
Novo further boosts evidence for semaglutide’s heart benefits beyond weight loss: #ACC24
Novo Nordisk’s semaglutide has hit a pair of primary endpoints in a late-stage test in patients with a trio of cardiometabolic conditions, bolstering the company’s